Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/37230
Title: | Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening | Authors: | Dusabimana, Alfred Fodjo, Joseph Nelson Siewe Ndahura, Michel Mandro Mmbando, Bruno P. Jada, Stephen Raimon Boven, Annelies De Smet, Eric Ukety, Tony Njamnshi, Alfred K. Laudisoit, Anne ABRAMS, Steven Colebunders, Robert |
Issue Date: | 2022 | Publisher: | MDPI | Source: | PATHOGENS, 11 (3) , (Art N° 281) | Abstract: | To eliminate onchocerciasis-associated morbidity, it is important to identify areas where there is still high ongoing Onchocerca volvulus transmission. Between 2015 and 2021, door-to-door surveys were conducted in onchocerciasis-endemic villages in Cameroon, the Democratic Republic of Congo (DRC), Nigeria, South Sudan, and Tanzania to determine epilepsy prevalence and incidence, type of epilepsy and ivermectin therapeutic coverage. Moreover, children aged between six and 10 years were tested for anti Onchocerca antibodies using the Ov16 IgG4 rapid diagnostic test (RDT). A mixed-effect binary logistic regression analysis was used to assess significantly associated variables of Ov16 antibody seroprevalence. A high prevalence and incidence of epilepsy was found to be associated with a high Ov16 antibody seroprevalence among 6-10-year-old children, except in the Logo health zone, DRC. The low Ov16 antibody seroprevalence among young children in the Logo health zone, despite a high prevalence of epilepsy, may be explained by a recent decrease in O. volvulus transmission because of a decline in the Simulium vector population as a result of deforestation. In the Central African Republic, a new focus of O. volvulus transmission was detected based on the high Ov16 IgG4 seropositivity among children and the detecting of nodding syndrome cases, a phenotypic form of onchocerciasis-associated epilepsy (OAF). In conclusion, Ov16 IgG4 RDT testing of 6-10-year-old children is a cheap and rapid method to determine the level of ongoing O. volvulus transmission and to assess, together with surveillance for OAE, the performance of onchocerciasis elimination programs. | Notes: | Colebunders, R (corresponding author), Univ Antwerp, Global Hlth Inst, Doornstr 331, B-2610 Antwerp, Belgium. alfred.dusabimana@uantwerpen.be; josephnelson.siewefodjo@uantwerpen.be; michelmandro8@gmail.com; b.mmbando@yahoo.com; stephen.jada@amref.org; annelies.boven@student.uantwerpen.be; eric.de.smet@telenet.be; tony.ukety@gmail.com; alfred.njamnshi@brainafrica.org; laudisoit@ecohealthalliance.org; steven.abrams@uantwerpen.be; robert.colebunders@uantwerpen.be |
Keywords: | onchocerciasis; onchocerciasis-associated epilepsy; epilepsy prevalence;;incidence; ivermectin; OV16 antibodies; Africa | Document URI: | http://hdl.handle.net/1942/37230 | e-ISSN: | 2076-0817 | DOI: | 10.3390/pathogens11030281 | ISI #: | WOS:000774256200001 | Rights: | © 2022 by the authors.Licensee MDPI, Basel, Switzerland.This article is an open access articledistributed under the terms andconditions of the Creative CommonsAttribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2023 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening _ Enhanced Reader.html | Published version | 211.01 kB | HTML | View/Open |
WEB OF SCIENCETM
Citations
5
checked on Sep 8, 2024
Page view(s)
52
checked on Sep 6, 2022
Download(s)
6
checked on Sep 6, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.